A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
Clinical trial NCT03248531 · COMPLETED
Trial details
- NCT number
- NCT03248531
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-22
- Primary completion
- 2018-11-23
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.